Abstract
We evaluate the short-term effect of a Fraxinus excelsior L. seed extract, named FraxiPure (FRP) on spontaneously hypertensive rats (SHR). Water, Captopril and different doses of FRP were orally administered. Blood pressure was recorded by the tail cuff method and plasma samples were collected to determine antioxidant capacity and malondialdehyde equivalents. In other trials, 18h fasted SHR were administered water, FRP, Furosemide, Torasemide, and Captopril. In these animals, urine was collected for 4h to obtain the urine volumetric excretion (UVE). Plasma samples of these animals were used to establish the fractional excretion (FE) of different ions (Na+, Cl−, K+, Ca2+ and PO43−) and metabolites (creatinine, urea and uric acid).FRP shows antihypertensive effect. The decrease in blood pressure caused by FRP was slightly lower than that of Captopril and more accentuated than that of Torasemide. FRP and Torasemide significantly increased UVE. Torasemide significantly increased FE(Na+) and FE(Cl−) and showed a clear uricosuric effect. FRP showed slight natriuretic effects and behaved as a potassium-sparing diuretic. FRP significantly increased plasma antioxidant capacity and decreased plasma malondialdehyde equivalents. The antihypertensive effect of FRP in SHR can therefore be related with its diuretic and antioxidant properties.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.